Exact Sciences Corporation
EXAS
$101.25
$0.050.05%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 850.74M | 811.09M | 706.79M | 713.42M | 708.66M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 850.74M | 811.09M | 706.79M | 713.42M | 708.66M |
| Cost of Revenue | 266.81M | 248.63M | 206.24M | 284.13M | 217.17M |
| Gross Profit | 583.93M | 562.45M | 500.55M | 429.29M | 491.49M |
| SG&A Expenses | 467.72M | 450.79M | 476.71M | 442.51M | 408.49M |
| Depreciation & Amortization | -- | -- | -- | -71.06M | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 851.75M | 808.32M | 788.26M | 755.20M | 727.15M |
| Operating Income | -1.01M | 2.76M | -81.47M | -41.77M | -18.50M |
| Income Before Tax | -17.76M | -57.00K | -100.99M | -875.97M | -37.43M |
| Income Tax Expenses | 1.84M | 1.13M | 224.00K | -11.38M | 808.00K |
| Earnings from Continuing Operations | -19.59M | -1.19M | -101.22M | -864.59M | -38.24M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -19.59M | -1.19M | -101.22M | -864.59M | -38.24M |
| EBIT | -1.01M | 2.76M | -81.47M | -41.77M | -18.50M |
| EBITDA | 54.87M | 58.05M | -27.41M | 11.37M | 36.28M |
| EPS Basic | -0.10 | -0.01 | -0.54 | -4.67 | -0.21 |
| Normalized Basic EPS | 0.02 | 0.02 | -0.29 | -0.14 | -0.06 |
| EPS Diluted | -0.10 | -0.01 | -0.54 | -4.67 | -0.21 |
| Normalized Diluted EPS | 0.02 | 0.02 | -0.29 | -0.14 | -0.06 |
| Average Basic Shares Outstanding | 189.26M | 188.90M | 186.81M | 185.31M | 184.80M |
| Average Diluted Shares Outstanding | 189.26M | 188.90M | 186.81M | 185.31M | 184.80M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |